TRP-2 peptide-based therapeutic cancer vaccine (Vical)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTRP-2 peptide-based therapeutic cancer vaccine (Vical)
Drug Alias Nametherapeutic cancer vaccine (tyrosinase-related protein 2 peptide-based) (Vical)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMacrophage migration inhibitory factor modulators
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFresh Tracks Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFresh Tracks Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A